View Single Post
  #7  
Old Mon Dec 13, 2010, 04:34 PM
akita akita is offline
Member
 
Join Date: Nov 2010
Posts: 110
Hi Lindy,

thank you for your interest. i have read the article again and also for me it is hard to understand, over all the practical use of the study: Is this mainly for Brazilia, to find out the immune thrombocytopenic MDs-patients from diagnosis on? If you have already big problems with your trombocytopenia and immune reactions to thrombo-concentrates, there is perhaps no doubt that you belong to the immune thrombozythopenic group..But the screening could ad least help patients at diagnosis helping to get no useless treatments.

Regards,

Margarete
__________________
Margarete, 54, living in Vienna, Austria,
MDS/AML M2, diagnosed 9/2007, then Chemos, aSZT 4/2008, chronic GVHD
Reply With Quote